TLR-activated B cells suppress T cell-mediated autoimmunity

Area of Science:

• Immunology
• Microbiology
• Autoimmunity

Background:

• Toll-like receptors (TLRs) are crucial for sensing microbial infections and regulating immune responses.
• B lymphocytes, macrophages, and dendritic cells express TLRs and the MyD88 adaptor protein.
• The role of TLR-activated B cells in T cell-mediated inflammation, particularly autoimmune diseases, remains largely unexplored.

Purpose of the Study:

• To investigate the impact of TLR-activated B cells on T cell-mediated autoimmune disease, specifically experimental autoimmune encephalomyelitis (EAE).
• To determine how B cell-specific TLR signaling influences inflammatory T cell responses and disease recovery.

Main Methods:

• Utilized genetically modified mice with B cell-restricted deficiencies in MyD88 or specific TLRs.
• Examined the development and progression of EAE in these mouse models.
• Analyzed T cell responses (Th1 and Th17) and disease recovery.

Main Results:

• TLR-signaling specifically within B cells was found to suppress inflammatory Th1 and Th17 cell responses.
• Activation of TLRs on B cells promoted recovery from EAE.
• Certain TLRs on B cells were essential for EAE resolution but not initiation, suggesting a distinct suppressive function.
• MyD88 signaling in B cells counteracted MyD88 signaling in other cells that drives Th17 differentiation and EAE induction.

Conclusions:

• B cells act as a critical link between microbial product recognition via TLRs and the suppression of T cell-mediated autoimmune diseases.
• TLR agonists, such as those from Mycobacterium tuberculosis, can preferentially trigger a regulatory function in B cells, limiting autoimmune pathology.
• Targeting TLR-B cell interactions may offer a novel therapeutic strategy for autoimmune conditions.